New Biotinylated GHK and Related Copper(II) Complex: Antioxidant and Antiglycant Properties In Vitro against Neurodegenerative Disorders
Molecules · 20.09.2023 · 28 (18) · 6724
DOI: 10.3390/molecules28186724 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 20.09.2023. Verfasst von Rita Tosto und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Crystallography, National Research Council of Italy (CNR), P. Gaifami 18, 95126 Catania, Italy. Hauptthemen laut MEDLINE: Antioxidants, Alzheimer Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute of Crystallography, CNR.
Abstract (Originalsprache)
Neurodegenerative diseases affect millions of people worldwide. The failure of the enzymatic degradation, the oxidative stress, the dyshomeostasis of metal ions, among many other biochemical events, might trigger the pathological route, but the onset of these pathologies is unknown. Multi-target and multifunctional molecules could address several biomolecular issues of the pathologies. The tripeptide GHK, a bioactive fragment of several proteins, and the related copper(II) complex have been largely used for many purposes, from cosmetic to therapeutic applications. GHK derivatives were synthesized to increase the peptide stability and improve the target delivery. Herein we report the synthesis of a new biotin–GHK conjugate (BioGHK) through orthogonal reactions. BioGHK is still capable of coordinating copper(II), as observed by spectroscopic and spectrometric measurements. The spectroscopic monitoring of the copper-induced ascorbate oxidation was used to measure the antioxidant activity Cu(II)-BioGHK complex, whereas antiglycant activity of the ligand towards harmful reactive species was investigated using MALDI-TOF. The affinity of BioGHK for streptavidin was evaluated using a spectrophotometric assay and compared to that of biotin. Finally, the antiaggregant activity towards amyloid-β was evaluated using a turn-on fluorescent dye. BioGHK could treat and/or prevent several adverse biochemical reactions that characterize neurodegenerative disorders, such as Alzheimer’s disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Crystallography, National Research Council of Italy (CNR), P. Gaifami 18, 95126 Catania, Italy.
- Department of Chemical Sciences, University of Catania, A. Doria 6, 95125 Catania, Italy.
ORCID-Profile: Graziella Vecchio, Francesco Bellia
Förderung
- Institute of Crystallography
- CNR
Zitieren
APA
Tosto, R., Vecchio, G., & Bellia, F. (2023). New Biotinylated GHK and Related Copper(II) Complex: Antioxidant and Antiglycant Properties In Vitro against Neurodegenerative Disorders. Molecules, 28(18), 6724. https://doi.org/10.3390/molecules28186724
Vancouver
Tosto R, Vecchio G, Bellia F. New Biotinylated GHK and Related Copper(II) Complex: Antioxidant and Antiglycant Properties In Vitro against Neurodegenerative Disorders. Molecules. 2023;28(18):6724. doi:10.3390/molecules28186724
BibTeX
@article{Tosto2023,
author = {Tosto, Rita and Vecchio, Graziella and Bellia, Francesco},
title = {New Biotinylated GHK and Related Copper(II) Complex: Antioxidant and Antiglycant Properties In Vitro against Neurodegenerative Disorders},
journal = {Molecules},
year = {2023},
volume = {28},
number = {18},
pages = {6724},
doi = {10.3390/molecules28186724}
}
EUVIMED